Challenges and opportunities in the off-patent sector

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at Sandoz. Rebecca speaks about generics and biosimilars: what they are, why they’re important for medication access and healthcare cost sustainability, and what Sandoz has learned about succeeding in the off-patent world. She also touches on the patient stories behind the headlines and the effect of COVID-19 on the generics market.